All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) · Represents pharmaceutical research and biotechnology companies

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 19, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Medicare/Medicaid

Legislative issues related to Medicare Part B prescription drug reimbursement. Pharmacy Benefit Management Reform in Medicare Part D, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Health Issues

Monitor implementation of the 340B Prescription Drug Discount Program and implementation of the Inflation Reduction Act of 2022 (P.L. No: 117-169). Issues regarding FDA user fee programs. Pharmacy Benefit Management Reform. Public health issues impacting patient access to treatments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.